Chemical and Pharmaceutical Bulletin p. 1463 - 1473 (1994)
Update date:2022-08-05
Topics: Synthesis Structure-activity relationships antihypertensive Dopaminergic
Ohno
Adachi
Koumori
Mizukoshi
Nagasaka
Ichihara
Kato -
A series of new (5R,8R,10R)-ergoline derivatives was synthesized, and their antihypertensive and dopaminergic activities were tested in conscious spontaneously hypertensive rats and in rats with unilateral 6- hydroxydopamine-induced lesions of the substantia nigra. (5R,8R,10R)-6- Alkyl-8-ergolinemethanols, prepared from the corresponding ergolinecarboxylates, were converted to the tosylates, which were treated with various five-membered heterocycles containing nitrogen atoms to afford the new ergolines. (5R,8R,10R)-8-(1,2,4-Triazol-1-ylmethyl)-6-methylergoline (4s, maleate: BAM-1110) exhibited potent dopaminergic activity, about 18- fold greater than that of bromocriptine mesylate. (5R,8R,10R)-8-(1,2,4- Triazol-1-ylmethyl)-6-propylergoline (8b, fumarate: BAM-1602) showed extremely potent dopaminergic activity, being about 220 and 1.15 times more active than bromocriptine mesylate and pergolide mesylate, respectively. Several compounds exhibited potent antihypertensive activity. Structure- activity relationships for antihypertensive and dopaminergic activities are discussed.
View MoreChemtn Biological Technology Limited
website:http://chemin.lookchem.com/
Contact:15532449001
Address:LB BLDG,Qiaoxi district,Shijiazhuang,china
Contact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
website:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Wuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
Shenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Doi:10.1016/j.bmcl.2014.01.050
(2014)Doi:10.1002/anie.202106716
(2021)Doi:10.1021/jo500536b
(2014)Doi:10.1016/j.bmcl.2014.03.043
(2014)Doi:10.1134/S1070428014030063
(2014)Doi:10.1002/ejoc.201301717
(2014)